✦ LIBER ✦

P.3.d.062 An open-label extension study of lurasidone in patients with schizophrenia previously randomized to lurasidone or risperidone

✍ Scribed by Mattingly, G.; Tocco, M.; Cucchiaro, J.; Xu, J.; Pikalov, A.; Loebel, A.

Book ID: 127349087
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 58 KB
Volume: 24
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(14)70895-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.d.061 Effect of lurasidone or risper

P.3.d.061 Effect of lurasidone or risperidone on metabolic syndrome status in patients with schizophrenia: a post hoc analysis of a long-term study

✍ Newcomer, J.; Pikalov, A.; Watabe, K.; Cucchiaro, J.; Rajagopalan, K.; Loebel, A 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Predictors of adherence to atypical anti

Predictors of adherence to atypical antipsychotics (risperidone or olanzapine) in older patients with schizophrenia: an open study of 3½ years duration

✍ C. W. Ritchie; S. Harrigan; M. Mastwyk; S. Macfarlane; N. Cheesman; D. Ames 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

## Abstract ## Objective Although the evidence base for the use of antipsychotics in older people with schizophrenia is generally of low quality, it tends to support the use of atypical antipsychotics. Only limited information regarding longer term adherence to these apparently more effective drug

P03-80 - Quetiapine augmentation of amis

P03-80 - Quetiapine augmentation of amisulpride: an open-label, non-randomized study in patients with schizophrenia partially responsive to amisulpride

✍ Ladea, M.; Dumitrescu, M.R.; Sarpe, M.C. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 26 KB

Amisulpride augmentation of clozapine: a

Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine

✍ J. Munro; P. Matthiasson; S. Osborne; M. Travis; S. Purcell; A. M. Cobb; M. Laun 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

AOSOP6 Results from the 2-year open-labe

AOSOP6 Results from the 2-year open-label extension treatment phase of a pivotal phase 3 study of denosumab in patients with breast cancer and bone metastases previously treated with zoledronic acid or denosumab

✍ A.T. Stopeck; A. Lipton; M. Martín; J-J. Body; A. Paterson; G.G. Steger; K. Tonk 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 42 KB

A randomized, comparative, 3-arm, parall

A randomized, comparative, 3-arm, parallel group, open-label, multicenter study of the efficacy and safety of Bravelle™ (purified human FSH) and Repronex® when mixed in the same syringe and administered subcutaneously in continuous or sequential dose ratios to patients (34–40 years) undergoing in-vitro fertilization: interim data

✍ D.C. Marshall; M. Surrey; B. VanVoorhis; D. Kenigsberg; J.H. Check; P. McShane; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 29 KB